NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 10 மணி நேரத்திற்கு முன்இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Linc Q2 FY27 Earnings Call: Operating Income Up 10.8% YoY to ₹154.1 Cr, EBITDA Margin at 7.3%
Linc Limited released its Q2 FY27 earnings call transcript highlighting revenue growth offset by margin compression. Operating income grew 10.8% YoY to ₹15,412 lakhs (₹154.12 Cr), while operating EBITDA contracted 393 bps YoY to ₹1,131 lakhs (7.3% margin) due to raw material inflation (~190 bps) and higher sales promotions (~200 bps). Profit after tax stood at ₹419 lakhs (2.7% margin) with a cash conversion cycle of 70 days. Management indicated that commercial production at its new West Bengal facility is slated for Q4 (end of December to January), aimed at boosting operational efficiencies.
உச்சம் நம்பிக்கை
என்ன மாறியதுSubmission of the formal transcript of the Q2 FY27 investor conference call held on November 6, 2026.
ஏன் இது முக்கியம்Provides management commentary on input cost pressure (responsible for a ~190 bps margin hit), promotional spending impacts, and structural timelines for shifting operations to the new West Bengal plant.
Operating Income (Q2): ₹15,412 லட்சம்Operating EBITDA (Q2): ₹1,131 லட்சம்EBITDA லாப வரம்பு: 7.3%PAT (Q2): ₹419 லட்சம்Fixed Asset Turnover: 3.74 times
📅 குறுகிய காலம்Margins remain under near-term pressure from elevated input costs and promotion expenses, although management expects early signs of margin stabilization by Q4.
📈 நீண்ட காலம்Long-term operating leverage depends on successfully transitioning to the modernized West Bengal manufacturing facility and expanding higher-margin product lines like Pentonic and allied stationery.
⚠ அபாய எச்சரிக்கைகள்
Crude-oil-linked raw material price volatility
EBITDA margin compression from intense competition and elevated promotional spending
👀 கவனிக்க வேண்டியவை
Track the commissioning and operational handover of the West Bengal plant in Q4 FY27 and watch whether raw material price moderation improves EBITDA margins back toward historical double-digit levels.
Linc Q2 PAT drops 50.5% YoY to ₹4.19 Cr despite 10.8% revenue growth; margins contract
Linc Limited reported Q2 operating income of ₹154.12 Cr (₹15,412 Lakhs), up 10.8% YoY, supported by sales promotions and non-writing categories. However, Operating EBITDA dropped 27.8% YoY to ₹11.31 Cr, with margins contracting by 393 bps to 7.3% due to higher raw material costs and sales spend. Consequently, Net Profit (PAT) declined 50.5% YoY to ₹4.19 Cr (₹419 Lakhs) with EPS falling to ₹0.70. The company shifted from net cash to net debt of ₹22.37 Cr as of September 30, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுLinc published its Q2 investor presentation, disclosing a sharp contraction in operating margin from 11.3% to 7.3% and a 50.5% drop in PAT.
ஏன் இது முக்கியம்Demonstrates limited pricing power in a price-sensitive stationery market as polymer inflation and increased promotional spending cut profitability by half.
Q2 Operating Income: ₹15,412 லட்சம்Q2 Operating EBITDA: ₹1,131 லட்சம்Q2 PAT: ₹419 லட்சம்EBITDA Margin Contraction: 393 bpsNet Debt as on Sep 30, 2026: ₹2,237 லட்சம்
📅 குறுகிய காலம்Profitability headwinds and margin squeeze are likely to weigh on sentiment following a 50.5% YoY drop in quarterly PAT.
📈 நீண்ட காலம்Long-term recovery hinges on expanding higher-margin products (like Pentonic), stabilizing raw material sourcing, and turning overseas JV initiatives profitable.
⚠ அபாய எச்சரிக்கைகள்
Raw material price volatility (crude-linked polymers) impacting margins
Inability to fully pass cost inflation to consumers due to intense competition
Transition from net cash positive to net debt of ₹22.37 Cr
👀 கவனிக்க வேண்டியவை
Track whether polymer/input cost pressures abate in subsequent quarters and assess if heightened sales promotional expenses successfully stabilize market share without further hurting margins.
Q2 FY27 Net Profit Drops 67% YoY to ₹3.32 Cr Despite 9.4% Revenue Growth
Linc Limited reported its Q2 FY27 standalone financial results, with revenue from operations growing 9.4% YoY to ₹148.44 Cr compared to ₹135.63 Cr in Q2 FY26. However, standalone net profit plunged 67.3% YoY to ₹3.32 Cr from ₹10.16 Cr, driven by higher raw material costs and increased other expenses. Basic EPS fell to ₹0.56 from ₹1.71 in the year-ago period. Operating cash flow for H1 FY27 dropped sharply to ₹0.42 Cr from ₹26.25 Cr in H1 FY26, primarily due to an inventory buildup of ₹36.41 Cr.
உச்சம் நம்பிக்கை
என்ன மாறியதுLinc declared its Q2 and H1 FY27 financial results showing sharp margin compression and an earnings drop despite revenue growth.
ஏன் இது முக்கியம்Operating profits have shrunk considerably despite top-line expansion, and cash flows have turned tight due to inventory accumulation and higher short-term borrowing.
📅 குறுகிய காலம்Negative sentiment is likely given the steep year-on-year drop in profitability and cash generation.
📈 நீண்ட காலம்Profitability remains vulnerable to input cost fluctuations and intense pricing competition in writing instruments; execution on higher-margin brands (e.g., Pentonic) will be key.
⚠ அபாய எச்சரிக்கைகள்
Sharp drop in operating cash flows due to working capital drag (inventories rose by ₹36.41 Cr in H1)
Unprovided GST dispute of ₹7.07 Cr (tax + penalty) under appeal
Rising short-term debt levels
👀 கவனிக்க வேண்டியவை
Track operating margin recovery and raw material cost absorption in upcoming quarters, as well as the unwinding of working capital and inventory.
Lincoln Pharma Q2 Revenue Up 17.1% YoY to ₹191.35 Cr; PAT Up 2.2% to ₹20.43 Cr
Lincoln Pharmaceuticals reported standalone Q2 FY27 revenue from operations of ₹191.35 crore, up 17.1% YoY compared to ₹163.36 crore in Q2 FY26. Standalone net profit stood at ₹20.43 crore, a modest increase of 2.2% YoY from ₹19.98 crore, but down 43.6% QoQ primarily due to higher other income recognized in the previous quarter. For H1 FY27, revenue reached ₹368.63 crore with net profit of ₹56.66 crore compared to ₹47.66 crore in H1 FY26. Diluted EPS for the quarter was ₹10.20 compared to ₹9.98 in the year-ago period.
உச்சம் நம்பிக்கை
என்ன மாறியதுLincoln Pharmaceuticals declared its unaudited standalone financial results for Q2 and H1 ended September 30, 2026.
ஏன் இது முக்கியம்Top-line growth remains steady at ~17% YoY, aligning with the company's 16% growth targets, though bottom-line growth slowed YoY in Q2 due to elevated operating and raw material expenses.
Q2 FY27 Revenue from Operations: ₹191.35 கோடிQ2 FY27 Net Profit: ₹20.43 கோடிH1 FY27 Revenue from Operations: ₹368.63 கோடிH1 FY27 Net Profit: ₹56.66 கோடிQ2 FY27 Diluted EPS: ₹10.20
📅 குறுகிய காலம்Likely neutral reaction as steady revenue growth is offset by flattish YoY profit and a sequential profit drop from Q1.
📈 நீண்ட காலம்Expansion into regulated markets (EU GMP, TGA Australia) and commercialization of new products provide steady growth potential toward targeted ₹750 Cr revenue.
⚠ அபாய எச்சரிக்கைகள்
Input cost inflation shown by higher cost of materials consumed (₹77.47 Cr vs ₹57.20 Cr YoY)
Foreign exchange volatility affecting export realizations across 60+ destination markets
👀 கவனிக்க வேண்டியவை
Track the pace of export penetration into regulated markets following EU GMP and TGA Australia approvals, as well as operational margin stability across H2 FY27.
Lincoln Pharma Sets Sept 11, 2026 as Record Date for ₹1.80/Share (18%) Final Dividend
Lincoln Pharmaceuticals Limited has fixed Friday, September 11, 2026, as the record date for determining shareholder entitlement to a final dividend of ₹1.80 per equity share (18% on face value of ₹10) for FY 2025-26. The payment remains subject to shareholder approval at the company's 32nd Annual General Meeting scheduled for September 30, 2026. At the current market price of ₹615, the dividend translates to a dividend yield of ~0.29%. The share transfer books will remain closed from September 12, 2026, to September 30, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுLincoln Pharma has formalized the record date and AGM timeline for the distribution of its FY26 final dividend.
ஏன் இது முக்கியம்Defines the exact cut-off timeline for shareholders to receive the ₹1.80 per share cash distribution from FY26 profits.
Final dividend per share: ₹ 1.80Dividend percentage: 18%ரெக்கார்ட் தேதி: 11-செப்.-2026AGM date: 30-செப்.-2026Dividend yield at ₹615: ~0.29%
📅 குறுகிய காலம்Stock will trade ex-dividend leading into the September 11, 2026 record date with negligible price impact given the small yield (~0.29%).
📈 நீண்ட காலம்Limited; routine annual capital allocation and dividend distribution.
👀 கவனிக்க வேண்டியவை
Investors tracking dividend payouts should note the September 11, 2026 record date and track the outcome of the 32nd AGM on September 30, 2026.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
31% YoY PAT Growth in Q1 FY27; Revenue Rises 15% to ₹177.3 Cr
Lincoln Pharmaceuticals reported a strong start to FY27 with a 30.9% YoY increase in Net Profit to ₹36.23 Cr. Revenue from operations grew 15.1% YoY to ₹177.28 Cr, representing approximately 26.4% of its TTM revenue. Profitability was significantly higher than the preceding quarter (Q4 FY26 PAT was ₹11.63 Cr), supported by a recovery in margins. The company maintains a robust financial position with a near-zero debt-to-equity ratio of 0.01.
உச்சம் நம்பிக்கை
என்ன மாறியதுLincoln Pharmaceuticals released its Q1 FY27 results, showing a significant recovery in profitability compared to the previous quarter and strong double-digit growth on a YoY basis.
ஏன் இது முக்கியம்The results demonstrate the company's ability to scale its formulations business and maintain margins despite a high export exposure (60+ countries). The strong EPS growth supports the current P/E valuation of 13.9x.
Revenue (Q1 FY27): ₹177.28 கோடிNet Profit (Q1 FY27): ₹36.23 கோடிYoY PAT Growth: 30.9%Q1 வருவாய் vs TTM வருவாய்: 26.4%EPS (Q1 FY27): ₹18.09
📅 குறுகிய காலம்The stock may see positive sentiment in the short term as the market reacts to the 31% YoY profit growth and the sharp sequential recovery from Q4 FY26.
📈 நீண்ட காலம்Structural growth depends on the successful entry into high-value regulated markets like Canada, Australia, and the EU, alongside the shift toward high-margin chronic and lifestyle segments.
Regulatory risks associated with EU GMP and TGA standards
👀 கவனிக்க வேண்டியவை
Monitor the commercialization timeline of the Cephalosporin plant and the progress of the 700-product R&D pipeline, which are critical for reaching the management's ₹750 Cr revenue target.
1.4% Revenue Growth in Q1 FY27; EBITDA Margins Contract to 8.7% on High Input Costs
Linc Limited reported a modest 1.4% YoY revenue growth to ₹138.95 Cr for Q1 FY27, while PAT declined to ₹5.81 Cr. EBITDA margins contracted by 89 bps to 8.7% as the company faced elevated polymer prices, passing on only ~50% of the cost increase to the trade. E-commerce was a significant growth driver, rising 32% YoY, while corporate sales and exports declined by 14% and 3% respectively. Management has deferred formal guidance to Q2 FY27, citing continued volatility in raw material costs.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company is managing a period of margin compression due to input cost inflation while transitioning its sales mix toward e-commerce and preparing for new capacity.
ஏன் இது முக்கியம்The results highlight the sensitivity of the stationery business to crude oil prices and the importance of the upcoming West Bengal plant for future growth capacity.
📅 குறுகிய காலம்The stock may face pressure or remain range-bound in the short term due to margin contraction and the lack of immediate growth guidance.
📈 நீண்ட காலம்Long-term value depends on the successful scaling of the Pentonic brand and the operational efficiency of the new West Bengal manufacturing unit.
⚠ அபாய எச்சரிக்கைகள்
Raw material price volatility (crude-linked polymers)
Intense competition in a price-sensitive market
Geopolitical impacts on export revenue
👀 கவனிக்க வேண்டியவை
Monitor the commissioning and ramp-up of the West Bengal facility in Q3 FY27 and the recovery of margins as polymer prices normalize. Watch for formal management guidance expected in the Q2 FY27 earnings call.
1.4% Revenue Growth in Q1 FY27; PAT Declines 17.6% on Higher Input Costs
Linc Limited reported a marginal 1.4% YoY revenue growth to ₹138.95 Cr for Q1 FY27, but faced significant bottom-line pressure with PAT declining 17.6% to ₹5.81 Cr. EBITDA margins contracted by 89 bps to 8.7% primarily due to rising polymer prices driven by higher crude oil costs. While General Trade and E-commerce segments grew by 8% and 32% respectively, Corporate Sales fell 14% and Exports declined 3%. The company is maintaining a net-debt-free status with a negative net debt of ₹11.94 Cr.
உச்சம் நம்பிக்கை
என்ன மாறியதுLinc reported its Q1 FY27 financial results, showing a shift in growth towards e-commerce while facing margin compression from rising raw material costs.
ஏன் இது முக்கியம்The results highlight the company's vulnerability to crude-linked raw material prices and the importance of its upcoming capacity expansion for future growth.
Q1 FY27 Revenue: ₹138.95 கோடிYoY PAT Growth: -17.6%EBITDA லாப வரம்பு: 8.7%E-commerce Growth: 32%Planned Capex vs Market Cap: ~6.0%
📅 குறுகிய காலம்The stock may face pressure in the short term due to the double-digit decline in PAT and margin contraction despite stable revenue.
📈 நீண்ட காலம்Long-term growth depends on the successful ramp-up of the new West Bengal facility and the continued scaling of the high-margin Pentonic brand.
⚠ அபாய எச்சரிக்கைகள்
Rising crude oil prices impacting polymer costs
Intense competition limiting pricing power
Geopolitical risks affecting export revenue
👀 கவனிக்க வேண்டியவை
Investors should monitor the commissioning of the West Bengal facility in Q3 FY27 and the company's ability to pass through higher polymer costs to maintain margins in a competitive market.
Linc Limited reported a flat top-line performance for Q1 FY27, with total income growing just 0.9% YoY to ₹139.40 Cr. Profitability was significantly impacted as PAT fell 17.6% YoY to ₹5.81 Cr, and EBITDA margins contracted by 139 basis points to 9.0%. The margin decline was primarily driven by rising polymer prices (crude-linked raw materials) which the company has yet to fully pass through. While e-commerce grew 32% YoY, corporate sales and exports faced headwinds, declining 14% and 3% respectively.
உச்சம் நம்பிக்கை
என்ன மாறியதுLinc experienced a significant margin squeeze in Q1 FY27 due to raw material inflation, despite maintaining stable revenue levels.
ஏன் இது முக்கியம்The results highlight the company's vulnerability to crude-oil-linked input costs and a slowdown in corporate and export demand, which are typically higher-margin segments.
Total Income (Q1 FY27): ₹139.40 கோடிPAT (Q1 FY27): ₹5.81 கோடிEBITDA லாப வரம்பு: 9.0%E-commerce Growth: 32%Net Debt: ₹(11.94) CrQ1 வருவாய் vs TTM வருவாய்: 25.7%
📅 குறுகிய காலம்The stock may face pressure in the short term due to the double-digit decline in net profit and EBITDA margin contraction.
📈 நீண்ட காலம்Long-term growth depends on the successful ramp-up of the new West Bengal plant and the scaling of high-margin brands like Pentonic to counter commodity price volatility.
👀 கவனிக்க வேண்டியவை
Investors should monitor the commissioning timeline of the West Bengal facility in Q3 FY27 and the management's ability to implement price hikes to offset polymer cost inflation.
Linc Q1 FY27 Standalone PAT Drops 30% to ₹5.10 Cr; Board Revises Management Remuneration
Linc Limited reported a weak start to FY27 with standalone Profit After Tax (PAT) declining 30.4% YoY to ₹5.10 Cr, down from ₹7.33 Cr. Revenue remained nearly flat at ₹135.65 Cr compared to ₹134.30 Cr in the year-ago period, indicating stagnant growth. The board also approved the re-appointment of an Independent Director for 5 years and revised the annual remuneration for two key management personnel to ₹40 lakhs each. A significant contingent risk remains as the company contests a GST demand and penalty totaling approximately ₹7.06 Cr.
உச்சம் நம்பிக்கை
என்ன மாறியதுLinc reported its Q1 FY27 financial results showing a sharp profit decline despite stable revenue, alongside routine board approvals for director re-appointments and executive pay revisions.
ஏன் இது முக்கியம்The profit contraction highlights the company's struggle with cost management in a price-sensitive stationery market, while the GST dispute represents a potential liability equal to ~21% of TTM PAT.
Standalone Revenue (Q1 FY27): ₹135.65 கோடிStandalone PAT (Q1 FY27): ₹5.10 கோடிYoY PAT Growth: -30.4%GST Dispute Value: ₹7.06 கோடிRevised Remuneration (per person): ₹40.00 லட்சம்
📅 குறுகிய காலம்The stock is likely to face downward pressure in the short term due to the significant year-on-year decline in profitability and stagnant revenue growth.
📈 நீண்ட காலம்Long-term performance depends on the success of overseas JVs and the Deli brand expansion to diversify beyond the core writing instrument segment, which currently faces intense competition.
⚠ அபாய எச்சரிக்கைகள்
Margin compression
GST litigation risk (₹7.06 Cr)
Stagnant revenue growth
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's ability to scale its high-margin Pentonic brand to offset margin pressure and track the legal outcome of the ₹7.06 Cr GST dispute.
Linc Unveils First 'Stackoo' Experience Centre; Mumbai Launch Set for August 2026
Linc Limited has inaugurated its first retail outlet-cum-product experience centre under the brand 'Stackoo' at Park Street, Kolkata. This initiative is part of a strategic shift towards experiential retail to showcase its writing instruments and stationery portfolio, including the high-margin Pentonic brand. A second outlet is scheduled to open in August 2026 at Sky City Mall, Borivali, Mumbai. While the specific investment for these outlets was not disclosed, the company is currently deploying a ₹35 Cr capex plan to support its broader growth strategy.
உச்சம் நம்பிக்கை
என்ன மாறியதுLinc has transitioned from a purely distribution-led model to establishing its own branded experiential retail presence under the 'Stackoo' brand.
ஏன் இது முக்கியம்Direct-to-consumer retail allows for better brand positioning and higher visibility for premium products, which is critical for improving the current 11.0% operating margin in a price-sensitive industry.
Total Capex Plan: ₹35 கோடிCapex vs Market Cap: 5.8%Pentonic Sales Contribution: 34.2%TTM வருவாய்: ₹541 கோடிMumbai Launch Date: ஆகஸ்ட் 2026
📅 குறுகிய காலம்The announcement is sentimentally positive as it demonstrates brand-building intent, though the immediate financial impact of two stores on the ₹541 Cr revenue base will be minimal.
📈 நீண்ட காலம்If the 'Stackoo' model proves successful, a wider rollout could structurally improve Linc's brand equity and margins by reducing reliance on low-margin commodity products.
⚠ அபாய எச்சரிக்கைகள்
Execution risk in managing high-street retail operations
Potential for high fixed rental costs to impact short-term profitability
👀 கவனிக்க வேண்டியவை
Watch for management commentary in upcoming quarters regarding the sales throughput and margin profile of these direct retail outlets compared to traditional distribution channels.
Linc Limited has appointed Mr. Krishna Kumar Gupta as Vice President - GT Sales, effective July 20, 2026. Mr. Gupta brings over 24 years of sales leadership experience from top-tier FMCG companies including Nestlé, Kellogg's India, and Perfetti Van Melle India. This appointment is strategic for Linc, which generates Rs 541 Cr in TTM revenue and is focused on scaling its high-margin Pentonic brand (34.2% of sales) through a robust distribution network. The addition of senior FMCG expertise is intended to drive sustainable business growth across North, East, and West India.
உச்சம் நம்பிக்கை
என்ன மாறியதுLinc has strengthened its senior management team by hiring a veteran from the FMCG sector to lead its General Trade (GT) sales division.
ஏன் இது முக்கியம்For a mid-cap company (Rs 629 Cr market cap) in a price-sensitive market, institutionalizing sales processes with top-tier FMCG talent is critical for scaling distribution and maintaining margins against unorganized players.
Experience of New VP: 24+ yearsPentonic Revenue Contribution: 34.2%TTM வருவாய்: Rs 541 கோடிPlanned Capex: Rs 35 கோடி
📅 குறுகிய காலம்The appointment of a high-caliber professional from Nestlé/Kellogg's is likely to be viewed positively by the market as a sign of professionalization.
📈 நீண்ட காலம்If successful, this leadership change could structurally improve Linc's distribution reach and product mix, supporting its 5.80% expected growth rate and margin expansion.
⚠ அபாய எச்சரிக்கைகள்
Execution risk in integrating new leadership into existing distribution channels
Intense competition from organized peers like DOMS and Flair
👀 கவனிக்க வேண்டியவை
Watch for improvements in sales execution and distribution efficiency in upcoming quarterly results, particularly regarding the penetration of high-margin stationery products.
Linc Ltd to Invest USD 250,000 in Turkish Joint Venture Silka Linc
Linc Limited has announced an additional investment of up to USD 250,000 (approximately ₹2.31 crore) in its Turkish joint venture, Silka Linc Kirtasiye Urunleri Sanayi Anonim Sirketi. The joint venture partner will contribute an equal amount, ensuring the shareholding remains at 50:50. The capital will be used for capital expenditure and working capital to support the JV's manufacturing and distribution of writing instruments in Turkey and surrounding regions. The JV showed significant growth with a turnover of ₹11.52 crore in FY 2025-26 compared to nil in the prior year.
முக்கிய அம்சங்கள்
Investment of up to USD 250,000 (approx. ₹2.31 crore) in the Turkish JV company.Maintains 50:50 ownership structure as the partner Silka contributes an equivalent amount.JV turnover grew to ₹11.52 crore in FY 2025-26 from nil in FY 2024-25.Funds to be utilized for capital expenditure and working capital requirements.Acquisition/investment expected to be completed within 3 months.
👀 கவனிக்க வேண்டியவை
Investors should monitor the scaling of Linc's international operations, as the Turkish JV is showing rapid turnover growth. While the investment amount is small relative to Linc's market cap, it signals a commitment to expanding the global manufacturing footprint.
Linc Ltd Q4 FY26 Results: PAT at ₹10.46 Cr, Revenue Declines 10.6% YoY to ₹137.67 Cr
Linc Limited reported a stable full-year FY26 operating income of ₹543 crores, although Q4 revenue declined 10.6% YoY to ₹137.67 crores due to muted corporate gifting and geopolitical headwinds in exports. Despite the revenue dip, Q4 Operating EBITDA margins improved by 41 bps to 12.9%, and the company maintained a strong net cash position of ₹6.86 crores. Management has warned that Q1 FY27 may reflect similar muted trends as Q4 FY26, but they are optimistic about long-term growth driven by a new West Bengal facility expected in Q3 FY27. The board has recommended a dividend of ₹1.5 per share.
முக்கிய அம்சங்கள்
FY26 Operating Income stood at ₹543 crores with an EBITDA margin of 11%, down 89 bps YoY.Q4 FY26 PAT reached ₹1,046 lakhs with a margin of 7.5%, despite a 10.6% decline in quarterly revenue.Added 125 frontline sales staff and split the sales team into mass and premium verticals to boost retail throughput.Board approved an additional $250,000 investment in the Turkish joint venture to support automation.New manufacturing facility in West Bengal for the Morris subsidiary is scheduled to be operational by Q3 FY27.
👀 கவனிக்க வேண்டியவை
Investors should monitor the impact of the new dual-vertical distribution strategy on General Trade growth and the commissioning of the West Bengal plant in Q3 FY27. While near-term headwinds persist in exports and raw material costs, the company's focus on premiumization and distribution expansion remains a key long-term driver.
Lincoln Pharma Recommends ₹1.80 Dividend; FY26 Net Profit Rises to ₹87.89 Crore
Lincoln Pharmaceuticals reported a steady performance for the full year ended March 31, 2026, with total income growing 9.1% to ₹704.48 crore. The company's annual net profit increased by 6.7% year-on-year to ₹87.89 crore, resulting in an improved EPS of ₹43.88. A final dividend of ₹1.80 per share (18%) has been recommended for shareholder approval. While annual growth is positive, the Q4 net profit remained relatively flat at ₹11.63 crore compared to the same period last year.
முக்கிய அம்சங்கள்
Recommended a final dividend of ₹1.80 per equity share (18% of face value) for FY26.Annual Revenue from Operations grew 7.7% year-on-year to ₹671.03 crore.Full-year Net Profit increased to ₹87.89 crore from ₹82.35 crore in the previous fiscal.Earnings Per Share (EPS) improved to ₹43.88 from ₹41.11 in FY25.Cash and cash equivalents increased to ₹21.09 crore as of March 31, 2026, up from ₹12.97 crore.
👀 கவனிக்க வேண்டியவை
Investors should consider the steady growth and consistent dividend payout as a sign of financial stability. The stock remains a solid hold for long-term investors given the healthy balance sheet and moderate earnings growth.
Linc Ltd Strategy Update: FY26 Revenue at ₹543 Cr and Net Debt Negative at ₹6.86 Cr
Linc Limited reported a steady FY26 with total revenue reaching ₹543 Crores, maintaining its scale while achieving a net-debt-free status with negative net debt of ₹6.86 Crores. The company's premiumization strategy is yielding results, with the Pentonic brand now contributing 34.4% of total revenue. Linc is diversifying its geographic footprint, reducing dependence on East India from 42% to 33% over seven years. Future growth is supported by a new manufacturing facility in West Bengal, expected to be operational by Q3 FY27, and strategic international joint ventures in Turkey, Kenya, and Korea.
முக்கிய அம்சங்கள்
FY26 Total Revenue stood at ₹543 Crores with a consistent dividend payout ratio of 27%.Achieved negative Net Debt of ₹686 lakhs, significantly improving from a peak debt of ₹6,194 lakhs in FY19.Pentonic brand revenue share reached 34.40% in FY26, driving the company's premiumization focus.Geographic diversification improved with West and South India revenue share rising to 37% from 27% in FY19.New West Bengal manufacturing facility is on track to become operational by Q3 FY27.
👀 கவனிக்க வேண்டியவை
Investors should focus on the company's transition to a high-margin product mix and its debt-free balance sheet. Monitor the timely commissioning of the West Bengal plant in late 2026 as a key catalyst for the next growth phase.
Linc Ltd Q4 FY26 PAT drops 13.6% YoY to ₹1,046 Lakhs; EBITDA Margins improve to 12.9%
Linc Limited reported a 10.6% YoY decline in Q4 FY26 revenue to ₹13,767 lakhs, primarily due to lower corporate sales and geopolitical headwinds affecting exports. Despite the revenue dip, operating EBITDA margins improved by 41 bps YoY to 12.9% in Q4, though full-year PAT fell 13.9% to ₹3,274 lakhs. The company remains net debt-free with a cash surplus of ₹686 lakhs and has recommended a dividend of ₹1.5 per share. Management highlighted rising polymer prices as a near-term challenge but expects strategic JVs and new product launches to drive future growth.
முக்கிய அம்சங்கள்
Q4 FY26 Revenue declined 10.6% YoY to ₹13,767 lakhs, while full-year FY26 revenue remained flat at ₹54,301 lakhs.Q4 PAT decreased by 13.6% YoY to ₹1,046 lakhs, impacted by a high base in corporate orders and export volatility.Operating EBITDA margin for Q4 improved to 12.9% (+41 bps YoY), reflecting disciplined cost management despite revenue pressure.The company maintains a strong balance sheet with a negative Net Debt of ₹686 lakhs and a dividend payout ratio of 27%.Management warned of rising polymer prices and limited immediate pricing power due to competitive dynamics in the near term.
👀 கவனிக்க வேண்டியவை
Investors should monitor the recovery in export markets and the company's ability to pass on rising raw material costs. While near-term growth is soft, the debt-free balance sheet and strategic JVs like Mitsubishi Pencil provide long-term stability.
Linc Ltd Recommends ₹1.50 Dividend; FY26 Net Profit Declines to ₹36.61 Crore
Linc Limited has recommended a final dividend of ₹1.50 per share (30% of face value) for FY26, with payment expected around September 4, 2026. The company reported a stagnant performance for the full year, with revenue remaining flat at ₹532.07 crore compared to ₹531.48 crore in FY25. Net profit for the year saw a 5.3% decline, dropping to ₹36.61 crore from ₹38.66 crore. The fourth quarter was particularly weak, with revenue falling 9.5% year-on-year to ₹136.66 crore.
முக்கிய அம்சங்கள்
Recommended a final dividend of ₹1.50 per equity share (30% of face value ₹5)Full-year FY26 Net Profit decreased to ₹36.61 crore from ₹38.66 crore in FY25Q4 FY26 Revenue from operations fell 9.5% YoY to ₹136.66 croreAnnual Earnings Per Share (EPS) declined to ₹6.15 from ₹6.50 in the previous yearAppointed Devanshi Jalan and Vridhi Aakash Jalan as Executives for Business Development
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's ability to revive top-line growth after a stagnant year and a weak fourth quarter. While the dividend provides some yield support, the slight margin compression and flat revenue suggest a cautious outlook in the near term.
Linc Limited to Invest ₹60.58 Crores for Capacity Expansion by Q3 FY27
Linc Limited has announced a significant update regarding its new manufacturing facility near its existing factory in Kolkata. The company plans to invest ₹60.58 Crores into this capacity addition project, which is now scheduled for completion by the third quarter of FY 2027. This expansion is part of a long-term growth strategy previously outlined in 2024 and 2025. The investment indicates the company's commitment to scaling production to meet future demand.
முக்கிய அம்சங்கள்
Total investment required for the new manufacturing unit is ₹60.58 CroresCapacity addition is proposed to be completed by Q3 of Financial Year 2027The new infrastructure is located near the company's existing factory in KolkataThis update follows previous regulatory submissions dated May 2024 and May 2025
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's quarterly progress on this capex and assess how the ₹60.58 Crore investment will be funded. The long-term production boost could drive revenue growth, but the benefits will only materialize starting late 2026.
Linc Ltd Invests Rs 5.61 Cr in Subsidiary Morris Linc for Expansion
Linc Limited has infused Rs 5.61 crore into its subsidiary, Morris Linc Private Limited, by subscribing to 56,05,235 equity shares at par. The joint venture partner, Morris Co. Ltd., has also contributed a matching amount of approximately Rs 5.60 crore to maintain the existing shareholding structure. These funds are specifically earmarked for capital expenditure and working capital to scale the subsidiary's writing instrument manufacturing business. Notably, Morris Linc's turnover has grown significantly from Rs 5.80 lakhs in FY25 to Rs 56.09 lakhs in FY26.
முக்கிய அம்சங்கள்
Investment of Rs 5.61 crore for 56,05,235 equity shares at Rs 10 eachJoint venture partner Morris Co. Ltd. contributed a matching Rs 5.60 croreSubsidiary turnover grew nearly 10x from Rs 5.80 lakhs in FY25 to Rs 56.09 lakhs in FY26Linc Limited maintains its majority control with a 50.01% stakeCapital will be utilized for manufacturing capacity expansion and working capital
👀 கவனிக்க வேண்டியவை
Investors should monitor the subsidiary's scaling progress as the 10x revenue growth suggests strong early traction. This capital infusion is a positive indicator of the company's commitment to its joint venture and manufacturing expansion.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
